Medscape is available in 5 Language Editions – Choose your Edition here.


Pediatric Hypochondriasis Clinical Presentation

  • Author: Maria Sandra Cely-Serrano, MD; Chief Editor: Caroly Pataki, MD  more...
Updated: Mar 19, 2015


The key feature of hypochondriasis is abnormal concern that one is developing or has a serious illness. These persons may not claim particular symptoms but are often preoccupied with health and avoiding germs. They may focus excessively on minor bodily signs and are most troubled by their tendency to believe that these signs imply development of a severe condition. Despite of their concerns about having illnesses undiagnosed by physicians, these patients do not tend to show typical anxiety nor do they seem to have poor health despite excessive use of health remedies. They seem to overinterpret bodily signs and are not relieved by reassurances that they are healthy. Patients with hypochondriasis believe good health is defined as a relatively symptom-free state.

The onset of hypochondriasis can occur in people of any age and is associated with dissatisfaction with medical care, doctor shopping, and deteriorating interpersonal relationships. Hypochondriasis can occur as an independent disorder, considered primary hypochondriasis, or as secondary hypochondriasis when it is part of another underlying psychiatric disorder (eg, depression, anxiety disorder).

Children with a somatization disorder have heightened risk for psychiatric disorders, family dysfunction, functional impairment, and frequent use of health services. Headache is the most frequent somatic symptom, occurring in 50% of affected children and adolescents. Younger children show higher rates of abdominal symptoms than adolescents. A nonclinical sample of students reporting frequent headaches also reported additional symptoms of somatization, as well as depression and anxiety.[2]

Children with depression or anxiety report significantly higher rates of somatic symptoms (eg, headache) than children with other mental disorders. Unexplained somatic symptoms can indicate an undiagnosed anxiety or depressive disorder. Multiple somatic symptoms are associated with anxiety, lowered self-esteem, family conflicts, health problems, and obesity. Data also suggest that higher levels of family stressors and parental somatic symptoms predict higher levels of somatic symptoms in children.[3, 4]

Patients with hypochondriasis believe good health to be relatively symptom free and consider more symptoms indicative of sickness. This may contribute to some of the clinical features of hypochondriasis, including the numerous somatic symptoms, bodily preoccupation, resistance to reassurance, and pursuit of medical care.

Assessment aims include the following:

  • Determine that no other disorder, either physical or psychiatric, better accounts for the symptoms.
  • Establish a thorough account of the psychopathology and arrive at a psychological formulation of the problem. Determination of the most suitable mental health intervention for the patient is also necessary.
  • Initiate a successful therapeutic relationship with the patient. The patient should feel that an empathic and competent therapist conducted the assessment in a satisfactory and complete manner.

Assessment should elicit the following information from the patient:

  • A brief description (ie, history) of the problem, including onset, severity, and duration
  • Triggers, both internal and external
  • Mood state, particularly anxiety and depression
  • Effects of the problem on school, work, or both and on social relationships
  • Medical interventions and how the interventions were interpreted by the patient
  • Previous treatment and reason, if any, of failure
  • Previous episodes of health concern
  • History of physical illness in the patient or a relative or friend
  • Patient's expectation of treatment
  • Cognitive factors
    • Thoughts, images, or both that trigger health anxiety
    • Intrusive negative thoughts, images, or both
    • Evidence for faulty beliefs
    • Dysfunctional assumptions
    • Selective attention or memory for information about health
    • Preoccupation with health or illness
    • Increased body focus
  • Behavioral factors
    • Behaviors that trigger health anxiety
    • Abnormal illness behaviors (eg, checking, avoidance, reassurance-seeking
  • Physiologic factors
    • Physical symptoms that trigger health anxiety
    • Physical symptoms of anxiety
    • Physical symptoms caused by increased bodily focus and repetitive body checking

Assessment should include information from other sources such as relatives, medical records, and involved professionals. Assessment measures include the following:

  • Diaries of intrusive negative thoughts
  • Diaries of physical symptoms
  • Baseline ratings of health anxiety, need for reassurance, and disease conviction
  • Standardized questionnaires (eg, Illness Behavior Questionnaire, Illness Attitude Questionnaire)

The Multidimensional Inventory of Hypochondrial Traits (MITH) was developed as a 4-component instrument consisting of affective, cognitive, behavioral, and perceptual scales, which reliably and validly measures hypochondriasis. The MITH was developed for research and is not intended as a diagnostic instrument. This tool is the first attempt to build a differentiated model of hypochondriasis and to construct a valid measure based on the model. This tool was developed primary with adult patients. The correlated 4-factor model provides a coherent theoretical foundation upon which future research can be built.[5]

Functional somatic symptoms (FSSs) in children aged 5-7 years were studied and published in 2012. The study validates FSSs clinically and describes the classification and a number of conditions that many times are not applicable to young children.[6]



Different theories help explain the origin of somatoform disorders such as hypochondriasis.

  • Biologic causes: Genetic or familial factors play a significant role in predisposing an individual to somatoform disorders. These disorders may be associated with the following characteristics:
    • Low pain threshold
    • Impaired verbal communication
    • Patterns of information processing characterized by distractibility, impulsiveness, and failure to habituate to repetitive stimuli
  • Psychodynamic theories: These theories explain that an unconscious intrapsychic conflict, wish, or need is converted into somatic symptoms that symbolically express some aspect of the conflict and, at the same time, protect the individual from conscious awareness of it. By keeping the wish unconscious, the symptom minimizes anxiety and thus provides primary gain. A secondary gain is that the symptom provides an escape from unwanted consequences or responsibilities.
  • Trauma and abuse: According to some studies, an association among childhood physical or sexual abuse and conversion, somatization, and dissociative disorders is observed. [7]
  • Learning theory: A child with an injury or illness quickly learns the benefits of the sick role and may be reluctant to recover. Symptoms are reinforced by increased parental attention and avoidance of unpleasant responsibilities (eg, attending school). Having a role model in the family for the illness has been correlated with somatoform disorders.
  • Emotion and communication
    • Children who have difficulty expressing emotions verbally use symptoms to communicate distress.
    • High-achieving children who try to meet parental expectations may be unable to admit to themselves or to their parents that they are under too much pressure.
    • Physical symptoms may be used to express emotions in families in which overt emotional expression is discouraged.
    • Anxious or depressed children may express somatic symptoms to express their feelings.
  • Family systems: In this theory, somatization is initiated by specific family patterns; the child's symptoms maintain homeostasis in the family. The family may display the following 4 characteristic patterns:
    • Enmeshment or blurring of interpersonal boundaries
    • Overprotection, demonstrated as limiting the child's involvement in age-appropriate activities
    • Rigidity, demonstrated by difficulty with life transition events (eg, puberty)
    • Lack of conflict resolution because of aversion to conflict and finding ways to avoid points of disagreement
  • Environmental and social influences: Cultural factors influence the tendency to somatize and the choice of symptoms. In some cultures, somatic symptoms often are the initial symptoms for underlying anxiety or depressive disorders.
  • Interpersonal model: There is a growing literature that links childhood adversity to adult hypochondriasis. Noyes et al (2002) found in an adult study that hypochondrial patients more frequently report more traumatic events and substance abuse in the family members compared to controls. [8] In addition, parental overconcern about child's health was positively correlated with adult hypochondriasis, and maternal care was negatively correlated with somatic symptoms.
  • Association with other disorders: In an experimental analysis of hypochondriasis, subjects were exposed to personally relevant health-related stimuli under one of two conditions: (1) subsequently performing safety-checking behaviors or (2) subsequently being instructed not to perform such behaviors. [9] For subjects who performed safety-checking behaviors, feelings of anxiety were reduced. For patients who did not, a more gradual reduction of anxiety and urges was observed. These findings are relevant to hypochondriasis possible relationship to panic disorder and obsessive compulsive disorder. [10]
  • The restrictive concept of good health and misinterpretation of bodily symptoms as a sign of illness are highly specific characteristics of hypochondriasis. [11]
  • Hypochondriacal attitudes may reflect a general cognitive bias that is not limited to illness-related thoughts. Three cognitive processes have been considered: a pessimistic interpretation style, reduced ratings of familiarity, and a reduced positive appraisal of familiar stimuli. In general, a less positive appraisal of familiar experiences, which is unrelated to illness-related thoughts, may maintain hypochondrial concerns. A general distrustful attitude towards familiar procedures should be considered in hypochondriasis.
  • The term cyberchondriasis has been introduced to describe that searching for health information online may exacerbate health anxiety. [12]
Contributor Information and Disclosures

Maria Sandra Cely-Serrano, MD Developmental and Behavioral Pediatrician, Center for Child Development, Florida Hospital

Maria Sandra Cely-Serrano, MD is a member of the following medical societies: American Academy of Pediatrics, Society for Developmental and Behavioral Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Chief Editor

Caroly Pataki, MD Health Sciences Clinical Professor of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Caroly Pataki, MD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, New York Academy of Sciences, Physicians for Social Responsibility

Disclosure: Nothing to disclose.

Additional Contributors

Angelo P Giardino, MD, MPH, PhD Professor and Section Head, Academic General Pediatrics, Baylor College of Medicine; Senior Vice President and Chief Quality Officer, Texas Children’s Hospital

Angelo P Giardino, MD, MPH, PhD is a member of the following medical societies: Academic Pediatric Association, American Academy of Pediatrics, American Professional Society on the Abuse of Children, Harris County Medical Society, International Society for the Prevention of Child Abuse and Neglect, Ray E Helfer Society

Disclosure: Received grant/research funds from Health Resources and Services Administration (HRSA) Integrated Community Systems for CSHCN Grant for other; Received advisory board from Baxter Healthcare Corporation for board membership.


Anna Maria Wilms Floet, MD Assistant Professor, Assistant Professor of Pediatrics, Department of Pediatrics, Behavior and Developmental, University of Maryland School of Medicine

Anna Maria Wilms Floet, MD is a member of the following medical societies: American Academy of Pediatrics and Society for Developmental and Behavioral Pediatrics

Disclosure: Nothing to disclose.

  1. Bleichhardt G, Hiller W. Hypochondriasis and health anxiety in the German population. Br J Health Psychol. 2007 Nov. 12:511-23. [Medline].

  2. Esposito M, Roccella M, Gallai B, Parisi L, Lavano SM, Marotta R, et al. Maternal personality profile of children affected by migraine. Neuropsychiatr Dis Treat. 2013. 9:1351-8. [Medline]. [Full Text].

  3. Walker LS, Garber J, Greene JW. Somatic complaints in pediatric patients: a prospective study of the role of negative life events, child social and academic competence, and parental somatic symptoms. J Consult Clin Psychol. 1994 Dec. 62(6):1213-21. [Medline].

  4. Rask CU, Elberling H, Skovgaard AM, Thomsen PH, Fink P. Parental-reported health anxiety symptoms in 5- to 7-year-old children: the Copenhagen Child Cohort CCC 2000. Psychosomatics. 2012 Jan-Feb. 53(1):58-67. [Medline].

  5. Schwenzer M, Mathiak K. Hypochondriacal attitudes may reflect a general cognitive bias that is not limited to illness-related thoughts. Psychol Health. 2011 Aug. 26(8):965-73. [Medline].

  6. Rask CU. Functional somatic symptoms in 5-7 year old children: assessment, prevalence and co-occurrence. Dan Med J. 2012 Nov. 59(11):B4537. [Medline].

  7. Bailer J, Witthöft M, Wagner H, Mier D, Diener C, Rist F. Childhood maltreatment is associated with depression but not with hypochondriasis in later life. J Psychosom Res. 2014 Aug. 77(2):104-8. [Medline].

  8. Noyes R Jr, Stuart S, Langbehn DR, et al. Childhood antecedents of hypochondriasis. Psychosomatics. 2002 Jul-Aug. 43(4):282-9. [Medline].

  9. Abramowitz JS, Moore EL. An experimental analysis of hypochondriasis. Behav Res Ther. 2007 Mar. 45(3):413-24. [Medline].

  10. Torres AR, Ferrão YA, Shavitt RG, Diniz JB, Costa DL, do Rosário MC, et al. Panic Disorder and Agoraphobia in OCD patients: clinical profile and possible treatment implications. Compr Psychiatry. 2014 Apr. 55(3):588-97. [Medline].

  11. Weck F, Neng JM, Richtberg S, Stangier U. The restrictive concept of good health in patients with hypochondriasis. J Anxiety Disord. 2012 Dec. 26(8):792-8. [Medline].

  12. Muse K, McManus F, Leung C, Meghreblian B, Williams JM. Cyberchondriasis: fact or fiction? A preliminary examination of the relationship between health anxiety and searching for health information on the Internet. J Anxiety Disord. 2012 Jan. 26(1):189-96. [Medline].

  13. Sakai R, Nestoriuc Y, Nolido NV, Barsky AJ. The prevalence of personality disorders in hypochondriasis. J Clin Psychiatry. 2010 Jan. 71(1):41-7. [Medline].

  14. Greeven A. van Balkom AJ. Visser S. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a control randomized trial. American Journal of Psychiatry. 2007 jan. 164(1):91-9. [Medline].

  15. Thomson AB, Page LA. Psychotherapies for hypochondriasis. Cochrane Database Syst Rev. 2007 Oct 17. CD006520. [Medline].

  16. Eilenberg T, Kronstrand L, Fink P, Frostholm L. Acceptance and commitment group therapy for health anxiety - Results from a pilot study. J Anxiety Disord. 2013 Jun. 27(5):461-8. [Medline].

  17. Sorensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011 Feb. 41(2):431-41. [Medline].

  18. Warwick HM, Clark DM, Cobb AM, Salkovskis PM. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry. 1996 Aug. 169(2):189-95. [Medline].

  19. Weck F. Treatment of Mental Hypochondriasis: A Case Report. Psychiatr Q. 2013 Aug 10. [Medline].

  20. Schweitzer PJ, Zafar U, Pavlicova M, Fallon BA. Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. J Clin Psychopharmacol. 2011 Jun. 31(3):365-8. [Medline].

  21. Undefined.

  22. Abramowitz JS, Deacon BJ. Severe health anxiety: why it persists and how to treat it. Compr Ther. 2004 Spring. 30(1):44-9. [Medline].

  23. Albrecht S, Naugle AE. Psychological assessment and treatment of somatization: adolescents with medically unexplained neurologic symptoms. Adolesc Med. 2002 Oct. 13(3):625-41. [Medline].

  24. Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004 Mar 24. 291(12):1464-70. [Medline].

  25. Barsky AJ, Coeytaux RR, Sarnie MK, Cleary PD. Hypochondriacal patients' beliefs about good health. Am J Psychiatry. 1993 Jul. 150(7):1085-9. [Medline].

  26. Bouman TK, Visser S. Cognitive and behavioural treatment of hypochondriasis. Psychother Psychosom. 1998 Jul-Oct. 67(4-5):214-21. [Medline].

  27. Campo JV, Jansen-McWilliams L, Comer DM, Kelleher KJ. Somatization in pediatric primary care: association with psychopathology, functional impairment, and use of services. J Am Acad Child Adolesc Psychiatry. 1999 Sep. 38(9):1093-101. [Medline].

  28. Campo JV, Reich MD. Somatoform disorders. Netherton S, Walker CE, Holmes D, eds. Child and Adolescent Psychological Disorders: A Comprehensive Textbook. New York, NY: Oxford Univ Press; 1999. 320-43.

  29. Lewis M, ed. Child and Adolescent Psychiatry? A Comprehensive Textbook. Williams & Wilkins; 1996.

  30. Egger HL, Costello EJ, Erkanli A, Angold A. Somatic complaints and psychopathology in children and adolescents: stomach aches, musculoskeletal pains, and headaches. J Am Acad Child Adolesc Psychiatry. 1999 Jul. 38(7):852-60. [Medline].

  31. Escobar JI, Gara M, Waitzkin H, et al. DSM-IV hypochondriasis in primary care. Gen Hosp Psychiatry. 1998 May. 20(3):155-9. [Medline].

  32. Fallon BA, Schneier FR, Marshall R, et al. The pharmacotherapy of hypochondriasis. Psychopharmacol Bull. 1996. 32(4):607-11. [Medline].

  33. Fritz GK, Fritsch S, Hagino O. Somatoform disorders in children and adolescents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997 Oct. 36(10):1329-38. [Medline].

  34. Haugaard JJ. Recognizing and treating uncommon behavioral and emotional disorders in children and adolescents who have been severely maltreated:somatization and other somatoform disorders. Child Maltreat. 2004. May 9(2):169-76. [Medline].

  35. Hiller W, Leibbrand R, Rief W, Fichter MM. Differentiating hypochondriasis from panic disorder. J Anxiety Disord. 2005. 19(1):29-49. [Medline].

  36. Hitchcock PB, Mathews A. Interpretation of bodily symptoms in hypochondriasis. Behav Res Ther. 1992 May. 30(3):223-34. [Medline].

  37. Kellner R. Somatization and Hypochondriasis. New York, NY: Praeger-Greenwood; 1986.

  38. Lieb R, Pfister H, Mastaler M, Wittchen HU. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand. 2000 Mar. 101(3):194-208. [Medline].

  39. Livingston R, Witt A, Smith GR. Families who somatize. J Dev Behav Pediatr. 1995 Feb. 16(1):42-6. [Medline].

  40. Longley SL, Watson D, Noyes R Jr. Assessment of the hypochondriasis domain: the multidimentional inventory of hypochondriacal traits (MIHT). Psychol Assess. 2005. Mar 17(1):3-14. [Medline].

  41. Noyes R Jr, Happel RL, Yagla SJ. Correlates of hypochondriasis in a nonclinical population. Psychosomatics. 1999 Nov-Dec. 40(6):461-9. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.